(Q33501346)

27 July 2017

title

Maraviroc modelling strategy: use of early phase 1 data to support a semi-mechanistic population pharmacokinetic model (English)

1 reference

27 July 2017

1 reference

Barry Weatherley

1

1 reference

27 July 2017

Lynn McFadyen

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

British Journal of Clinical Pharmacology

27 July 2017

published in

1 reference

27 July 2017

volume

68

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

355-369

1 reference

Maraviroc for previously treated patients with R5 HIV-1 infection

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

A population pharmacokinetic meta-analysis of maraviroc in healthy volunteers and asymptomatic HIV-infected subjects

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

Drug-drug interactions and the pharmacotherapy of HIV infection.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

Drug interactions in the management of HIV infection

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2766474

Potential role for P-glycoprotein in the non-proportional pharmacokinetics of UK-343,664 in man

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19740392

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2009.03455.X

1 reference

27 July 2017

1 reference

27 July 2017

1 reference